Very few papers reported Bcl2 as a possible partner of these bio-profiles, despite it was clearly demonstrated as a significant prognostic marker in breast cancer [18–21], and is part of the hormonal-related Oncotype Dx signature. This evidence concerns the gene BCL2 and breast cancer.